Fortis Healthcare Ltd
FORTISFortis Healthcare Ltd
FORTIS
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 76.51 | 5.86 | 0.15% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.35 | 6.43 | 0.53% |
Forecast & Ratings
Detailed Forecast from 13 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Fortis Healthcare Limited is an integrated healthcare delivery service provider. The Company is engaged in establishing, administering hospitals, diagnostic centers and research centers.
Investor Presentation
View olderPeers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Global Health Ltd
Dr. Lal PathLabs Ltd
Narayana Hrudayalaya Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,615.75 | 5,311.12 | 4,848.88 | 5,038.17 | 4,908.40 | 4,262.45 | 6,297.97 | 6,696.05 | 7,239.45 | 7,380.43 | ||||||||||
Raw Materials | 941.67 | 999.86 | 1,004.08 | 918.14 | 985.49 | 974.48 | 1,403.37 | 1,454.65 | 1,603.25 | 5,930.26 | ||||||||||
| Power & Fuel Cost | 107.61 | 100.74 | 95.36 | 100.11 | 104.47 | 102.17 | 111.07 | 119.06 | 119.52 | |||||||||||
| Employee Cost | 830.41 | 910.41 | 902.25 | 916.96 | 919.25 | 851.32 | 972.94 | 1,046.88 | 1,119.53 | |||||||||||
| Selling & Administrative Expenses | 595.42 | 826.56 | 601.92 | 721.07 | 679.09 | 545.45 | 808.70 | 937.60 | 1,003.82 | |||||||||||
| Operating & Other expenses | 1,748.73 | 1,470.24 | 2,660.29 | 1,922.23 | 1,483.94 | 1,289.26 | 1,566.41 | 1,879.35 | 2,061.92 | |||||||||||
EBITDA | 391.91 | 1,003.31 | -415.02 | 459.66 | 736.16 | 499.77 | 1,435.48 | 1,258.51 | 1,331.41 | 1,450.17 | ||||||||||
| Depreciation/Amortization | 225.10 | 222.18 | 238.96 | 232.92 | 291.73 | 290.60 | 300.84 | 315.74 | 342.50 | 365.19 | ||||||||||
| PBIT | 166.81 | 781.13 | -653.98 | 226.74 | 444.43 | 209.17 | 1,134.64 | 942.77 | 988.91 | 1,084.98 | ||||||||||
| Interest & Other Items | 133.05 | 229.44 | 257.79 | 336.83 | 205.06 | 165.88 | 146.85 | 129.09 | 130.95 | 139.35 | ||||||||||
| PBT | 33.76 | 551.69 | -911.77 | -110.09 | 239.37 | 43.29 | 987.79 | 813.68 | 857.96 | 945.63 | ||||||||||
| Taxes & Other Items | 15.34 | 130.02 | 97.44 | 188.83 | 181.42 | 153.05 | 432.67 | 224.95 | 259.08 | 289.81 | ||||||||||
| Net Income | 18.42 | 421.67 | -1,009.21 | -298.92 | 57.95 | -109.76 | 555.12 | 588.73 | 598.88 | 655.82 | ||||||||||
| EPS | 0.40 | 8.60 | -19.48 | -4.69 | 0.77 | -1.45 | 7.35 | 7.80 | 7.93 | 8.69 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.13 | 0.12 |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fortis Healthcare Ltd | 83.78 | 5.86 | 0.15% |
| Apollo Hospitals Enterprise Ltd | 113.23 | 13.90 | 0.23% |
| Max Healthcare Institute Ltd | 90.61 | 11.40 | 0.15% |
| Global Health Ltd | 82.03 | 10.39 | — |
Price Comparison
Compare FORTIS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.95%
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Fortis Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Kotak Emerging Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.0783% | Percentage of the fund’s portfolio invested in the stock 3.05% | Change in the portfolio weight of the stock over the last 3 months 0.88% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 44/75 (+5) |
HDFC Mid-Cap Opportunities Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.9060% | Percentage of the fund’s portfolio invested in the stock 1.94% | Change in the portfolio weight of the stock over the last 3 months 0.52% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/79 (+14) |
Nippon India Growth Fund - Growth Option - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.7131% | Percentage of the fund’s portfolio invested in the stock 2.44% | Change in the portfolio weight of the stock over the last 3 months 0.43% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/102 (-4) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Fortis Healthcare Ltd
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 24, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Jul 24, 2024
Cash Dividend
Ex DateEx DateJul 20, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Jul 20, 2023
Net profit of Fortis Healthcare rose 1.58% to Rs 176.46 crore in the quarter ended September 2024 as against Rs 173.72 crore during the previous quarter ended September 2023. Sales rose 12.34% to Rs 1988.39 crore in the quarter ended September 2024 as against Rs 1769.95 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1988.391769.95 12 OPM %21.8718.65 - PBDT415.87313.14 33 PBT320.82229.02 40 NP176.46173.72 2 Powered by Capital Market - Live
Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
The Board of Fortis Healthcare at its meeting held on 09 October 2024 has approved the issuance of listed, senior, secured, rated, redeemable Non-Convertible Debenture (NCDs) aggregating for a value of up to Rs 1550 crore having a face value of Rs. 1,00,000 on private placement basis to the eligible investors. Powered by Capital Market - Live
The company will issue listed, senior, secured, rated, redeemable NCDs having a face value of Rs 1 lakh, aggregating up to Rs 1550 crore to the eligible investors including but not limited to identified anchor investors. These anchor investors include DBS Bank, The Hongkong and Shanghai Banking Corporation, through its GIFT FPI (HSBC), Citicorp Investment Bank (Singapore), Mizuho Bank, Singapore and such other foreign portfolio investors qualified during the bidding process on such terms and conditions as set out in the transaction documents to be entered into for the issue. These debentures have a tenure of 5 years and are proposed to be listed on BSE. Fortis Healthcare is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates 27 healthcare facilities (including JVs and O&M facilities). The company's network comprises approximately 4,500 operational beds. The company's consolidated net profit jumped 40.32% to Rs 174 crore on 12.19% rise in net sales to Rs 1,859 crore in Q1 FY25 over Q1 FY24. The scrip rose 1.69% end at Rs 607.15 on Wednesday, 9 October 2024. Powered by Capital Market - Live
Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 9 October 2024Powered by Capital Market - Live
The Board of Fortis Healthcare will meet on 09 October 2024 to consider fund raising by way of NCD issuance. Powered by Capital Market - Live
The Board of Fortis Healthcare has decided to designate Indrajit Banerjee, Independent Director (DIN: 01365405) as the Chairman of the Company with effect from 01 October 2024 till the vacancy is filled. Ravi Rajagopal, Chairman & Independent Director stepped down from the Board of the Company with effect from close of business hours on 30 September 2024, Powered by Capital Market - Live
Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 30 August 2024.Powered by Capital Market - Live
Net profit of Fortis Healthcare rose 48.50% to Rs 165.96 crore in the quarter ended June 2024 as against Rs 111.76 crore during the previous quarter ended June 2023. Sales rose 12.16% to Rs 1858.90 crore in the quarter ended June 2024 as against Rs 1657.41 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1858.901657.41 12 OPM %18.4316.40 - PBDT320.85248.49 29 PBT229.85169.25 36 NP165.96111.76 48 Powered by Capital Market - Live
Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 7.52%, vs industry avg of 10.02%
Decreasing Market Share
Over the last 5 years, market share decreased from 13.74% to 11.71%